Organigram Global Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.600
-0.040 (-2.44%)
At close: Sep 3, 2025, 4:00 PM
1.620
+0.020 (1.25%)
After-hours: Sep 3, 2025, 4:00 PM EDT
Organigram Global Revenue
Organigram Global had revenue of 70.79M CAD in the quarter ending June 30, 2025, with 72.41% growth. This brings the company's revenue in the last twelve months to 223.82M, up 50.01% year-over-year. In the fiscal year ending September 30, 2024, Organigram Global had annual revenue of 159.84M with 7.13% growth.
Revenue (ttm)
223.82M CAD
Revenue Growth
+50.01%
P/S Ratio
1.34
Revenue / Employee
249,243 CAD
Employees
898
Market Cap
219.17M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 159.84M | 10.64M | 7.13% |
Sep 30, 2023 | 149.21M | 3.40M | 2.33% |
Aug 31, 2022 | 145.81M | 66.65M | 84.19% |
Aug 31, 2021 | 79.16M | -7.63M | -8.79% |
Aug 31, 2020 | 86.80M | 6.38M | 7.94% |
Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
OGI News
- 1 day ago - Organigram Global Releases Landmark Report: Legal Cannabis Added $16B to Canada's GDP in 2024 - Business Wire
- 16 days ago - Organigram: The Capital Efficient Market Leader Trading At A Discount - Seeking Alpha
- 21 days ago - Organigram Global Inc. (OGI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Organigram Posts Wider Loss, Eyes Profitability In Near Term - Benzinga
- 21 days ago - Organigram Reports Record Third Quarter Fiscal 2025 Results - Business Wire
- 4 weeks ago - Organigram to Report Third Quarter Fiscal 2025 Results on August 13, 2025 - Business Wire
- 2 months ago - Organigram Global Scales U.S. Presence with Collective Project Direct-to-Consumer Launch in 25 States and Expansion of Hemp-Derived THC Beverage Portfolio - Business Wire
- 2 months ago - Americans Should Buy Canadian Cannabis Companies - Seeking Alpha